Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PG

Paul Alan Glossop — 25 Patents

Pfizer: 18 patents #185 of 5,153Top 4%
APAnacor Pharmaceuticals: 2 patents #52 of 93Top 60%
TSThe University Of Sheffield: 1 patents #43 of 262Top 20%
CLCambridge Enterprise Limited: 1 patents #278 of 688Top 45%
UAUS Army: 1 patents #2,854 of 341Top 840%
Sandwich, GB: #2 of 150 inventorsTop 2%
Overall (All Time): #158,593 of 4,157,543Top 4%
25 Patents All Time
Paul Alan Glossop has been granted 25 US patents while listed as an inventor at Pfizer. The first was granted in 2005 and the most recent in January 2024. Paul Alan Glossop ranks #158,593 of 4,157,543 US inventors in our database (top 3.8%). Patent records list Paul Alan Glossop in Sandwich, GB.

Patents per Year

Patents granted per year, 2005 to 2024Bar chart with a peak of 5 patents in 2009.peak 52005: 1 patents20052006: 2 patents2007: 4 patents20072009: 5 patents2010: 2 patents20102011: 1 patents2012: 2 patents20122013: 1 patents2014: 1 patents20142017: 1 patents2018: 1 patents20182021: 1 patents2022: 1 patents20222023: 1 patents2024: 1 patents2024

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11866436 Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof Marko Juhana Hyvonen, Paul Brear, David Robert Spring 2024-01-09
11691992 Oxaborole analogs and uses thereof Robert T. Jacobs, Yang Liu, Richard J. Sciotti, Jason D. Speake, Gavin Alistair Whitlock +3 more 2023-07-04
11400081 Compounds Gareth Richards, Timothy Michael Skerry, Joseph P. A. Harrity, Jean-Olivier Zirimwabagabo, Matthew John Tozer +3 more 2022-08-02
10961261 Oxaborole analogs and uses thereof Robert T. Jacobs, Yang Liu, Richard J. Sciotti, Jason D. Speake, Gavin Alistair Whitlock +3 more 2021-03-30
10065964 Pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors Gavin Alistair Whitlock 2018-09-04
9533989 Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors Gavin Alistair Whitlock 2017-01-03
8822439 Glucocorticoid receptor agonists David S. Millan, David Anthony Price 2014-09-02 $96,406,000
8486992 Carboxamide derivatives as muscarinic receptor antagonists Simon John Mantell, Anthony Wood, Christine WATSON 2013-07-16 $331,538,000
8268881 Carboxamide derivatives as muscarinic receptor antagonists Simon John Mantell, Anthony Wood, Christine WATSON 2012-09-18 $330,831,000
8263583 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide Kim James 2012-09-11 $292,344,000
8013019 Sulfonamide derivatives for the treatment of diseases Alan Daniel Brown, Mark Edward Bunnage, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more 2011-09-06 $533,448,000
7772223 Carboxamide derivatives as muscarinic receptor antagonists Simon John Mantell, Anthony Wood, Christine WATSON 2010-08-10 $126,194,000
7767715 Sulfonamide derivatives for the treatment of diseases Alan Daniel Brown, Mark Edward Bunnage, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more 2010-08-03 $307,895,000
7629358 Compounds useful for the treatment of diseases Alan Daniel Brown, Charlotte Alice Louise Lane, David Anthony Price, Russell Andrew Lewthwaite, Mark Edward Bunnage +2 more 2009-12-08 $355,902,000
7547731 Formamide derivatives for the treatment of diseases Alan Daniel Brown, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Kim James +1 more 2009-06-16 $205,302,000
7538141 Compounds for the treatment of diseases Alan Daniel Brown, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Kim James +1 more 2009-05-26
7528170 Sulfonamide derivatives for the treatment of diseases Alan Daniel Brown, Mark Edward Bunnage, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more 2009-05-05 $707,866,000
7482487 Phenylaminoethanol derivatives as β2 receptor agonists Alan Daniel Brown, Justin Stephen Bryans, Charlotte Alice Louise Lane, Simmon John Mantell 2009-01-27 $94,923,000
7268147 Compounds useful for the treatment of diseases Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite 2007-09-11 $324,501,000
7244766 Sulfonamide derivatives for the treatment of diseases Alan Daniel Brown, Mark Edward Bunnage, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more 2007-07-17 $333,650,000
7241810 Formamide derivatives for the treatment of diseases Alan Daniel Brown, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Kim James +1 more 2007-07-10 $150,041,000
7183294 Indole derivatives useful for the treatment of diseases Alan Daniel Brown, Justin Stephen Bryans, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite +1 more 2007-02-27 $200,898,000
7141586 Nicotinamide derivatives useful as PDE4 inhibitors Simon Bailey, Christopher Gordon Barber, Donald Middleton 2006-11-28 $226,606,000
7138527 Indole derivatives useful for the treatment of diseases Alan Daniel Brown, Justin Stephen Bryans, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite +1 more 2006-11-21 $296,227,000
6844362 Indole derivatives useful for the treatment of diseases Alan Daniel Brown, Justin Stephen Bryans, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite +1 more 2005-01-18 $194,723,000